Cargando…

Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells

Epithelial ovarian cancer is most lethal in female reproductive carcinomas owing to the high chemoresistance and metastasis, so more efficient therapeutic agents are terribly needed. A propadiene compound: 1-phenylpropadienyl phosphine oxide (PHPO), was employed to test the chemotherapeutic efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuqing, Yang, Lina, Wang, Jingshu, Liang, Fan, Chang, Bin, Gu, Huafen, Wang, Honglin, Yang, Gong, Chen, Yaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302979/ https://www.ncbi.nlm.nih.gov/pubmed/27494891 http://dx.doi.org/10.18632/oncotarget.11012

Ejemplares similares

Intermolecular Hydroaminoalkylation of Propadiene
por: Kaper, Tobias, et al.
Publicado: (2020)

Efficient propyne/propadiene separation by microporous crystalline physiadsorbents
por: Peng, Yun-Lei, et al.
Publicado: (2021)

A theoretical study of the gas-phase reactions of propadiene with NO(3): mechanism, kinetics and insights
por: Wang, Haomin, et al.
Publicado: (2023)

One-step removal of alkynes and propadiene from cracking gases using a multi-functional molecular separator
por: Wang, Qingju, et al.
Publicado: (2022)

Comprehensive genomic analysis of microenvironment phenotypes in ovarian cancer
por: Wang, Jingshu, et al.
Publicado: (2020)

6-Bromo-1-(1,2-propadienyl)-3-(2-propynyl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
por: Dahmani, S., et al.
Publicado: (2010)

Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer
por: Yang, Yuqi, et al.
Publicado: (2019)

CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer
por: Hu, Haoyang, et al.
Publicado: (2021)

Evaluation of Chemotherapeutic Compounds in the Reticuloses*
por: Paterson, Edith
Publicado: (1958)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
por: Liang, Fan, et al.
Publicado: (2019)

Clinical study of ultrasound and microbubbles for enhancing chemotherapeutic sensitivity of malignant tumors in digestive system
por: Wang, Yanjie, et al.
Publicado: (2018)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
por: Westbom, Catherine, et al.
Publicado: (2015)

Prediction of chemotherapeutic resistance in serous ovarian cancer with low-density custom microarray
por: Zhu, Hong-Lan, et al.
Publicado: (2020)

Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
por: Yang, Chen, et al.
Publicado: (2019)

Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents’ Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2022)

Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma
por: Tao, Yuquan, et al.
Publicado: (2018)

Four Chemotherapeutic Compounds That Limit Blood-Brain-Barrier Invasion by Toxoplasma gondii
por: Yan, Zijing, et al.
Publicado: (2022)

Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2017)

Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds
por: Chiarinelli, Jacopo, et al.
Publicado: (2019)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response
por: Sun, Nian-Kang, et al.
Publicado: (2014)

Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
por: Fedier, André, et al.
Publicado: (2022)

Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin
por: Hou, Kai, et al.
Publicado: (2021)

Cetuximab enhanced the efficacy of chemotherapeutic agent in ABCB1/P-glycoprotein-overexpressing cancer cells
por: Wang, Fang, et al.
Publicado: (2015)

High expression of neuroguidin increases the sensitivity of acute myeloid leukemia cells to chemotherapeutic drugs
por: Chen, Kejun, et al.
Publicado: (2015)

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
por: Liu, Duanyang, et al.
Publicado: (2018)

Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling
por: Lu, Lili, et al.
Publicado: (2016)

Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
por: Kosowska, Agnieszka, et al.
Publicado: (2020)

Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
por: Yin, Min, et al.
Publicado: (2023)

Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma
por: Chang, Chia-Ming, et al.
Publicado: (2017)

Dynamic cellular biomechanics in responses to chemotherapeutic drug in hypoxia probed by atomic force spectroscopy
por: Alhalhooly, Lina, et al.
Publicado: (2021)

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes
por: James, Nicole E., et al.
Publicado: (2019)

Morphological parameters of ovarian masses and accuracy of the risk of malignancy index in diagnosing ovarian malignancy
por: Adilgereyeva, Akmaral S., et al.
Publicado: (2022)

Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer
por: Markman, Maurie
Publicado: (2010)

Phosphorescence Monitoring of Hypoxic Microenvironment in Solid-Tumors to Evaluate Chemotherapeutic Effects Using the Hypoxia-Sensitive Iridium (III) Coordination Compound
por: Zeng, Yun, et al.
Publicado: (2015)

Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression
por: Chen, Jue, et al.
Publicado: (2015)

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis
por: Biaoxue, Rong, et al.
Publicado: (2016)

Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
por: Lu, Chia-Sing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t2h11merrsitdfg5q6vkvrd73h